Close

Prana Biotech (PRAN) Announces Initiation of Phase 1 Clinical Trial of PBT434 for Treatment of Parkinsonian Diseases

June 14, 2018 5:47 AM EDT Send to a Friend
Prana Biotechnology Ltd (NASDAQ PRAN) is pleased to announce it has received ethics committee approval and has commenced recruitment for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login